Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pro-SWAP: Targeted Prophylaxis for Prostate Biopsy
NCT03228108Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ciprofloxacin, trimethoprim + sulfamethoxazole, fosfomycin, pivmecillinam and amoxicillin + clavulanate in Infection (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Any registered clinical infectious complication at 7 days. Started Apr 2018; status: completed.
02
Drugs
ciprofloxacintrimethoprim + sulfamethoxazolefosfomycinpivmecillinamamoxicillin + clavulanate
03
Conditions
Infection
Beyond the preview
Go deeper on NCT03228108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03228108.